BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
1 Citation
93 Claims
- 1. A compound of formula (I):
- 24. A pharmaceutical composition comprising the compound of formula (I):
- 52. A pharmaceutical composition comprising the compound of formula (I-1):
-
57. A unit dose pharmaceutical composition comprising the compound of formula (I-1), or a crystalline form thereof, wherein the compound of formula (I-1) is present in an amount equivalent on a molar weight basis of about 0.1 mg to about 3.0 mg of the compound of formula (VIII-1).
-
58. A unit dose pharmaceutical composition comprising about 0.143 mg to about 4.3 mg of the compound of formula (I-1), or a crystalline form thereof, measured as about 0.1 mg to about 3.0 mg of the compound of formula (VIII-1), on a weight for weight basis.
- 59. A pharmaceutical composition comprising the compound of formula (I):
- 66. A pharmaceutical composition comprising the compound of formula (I) in a lyophilized powder:
- 72. A unit dose pharmaceutical composition comprising the compound of formula (I-1), in a lyophilized powder:
- 77. A unit dose pharmaceutical composition comprising the compound of formula (I-15), in a lyophilized powder:
-
82. A method for preparation of a pharmaceutical composition of the compound (I-1) as a lyophilized powder, the method comprising the steps:
-
(f-1) combining; i. water; ii. the compound (I-1); iii. glycine; iv. sodium citrate; and v. citric acid;
to form a mixture; and(f-2) lyophilizing the mixture.
-
-
83. A method for the preparation of a pharmaceutical composition of the compound (1-15) as a lyophilized powder, the method comprising the steps
(g-1) combining: -
i. an aqueous solvent mixture comprising water and tert-butyl alcohol; ii. the compound (VIII-15); iii. glycine; iv. sodium citrate; and v. citric acid;
to form a mixture; and(g-2) lyophilizing the mixture. - View Dependent Claims (84)
-
- 87. A liquid pharmaceutical composition comprising the compound of formula (I):
-
91. A unit dose liquid pharmaceutical composition comprising the compound of formula
(I-1):
Specification